Adaptimmune Therapeutics plc (ADAPY) Financials

ADAPY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 130.6 million 201.6 million
March 31, 2025 158.1 million 195.5 million
Dec. 31, 2024 246.0 million 234.1 million
Sept. 30, 2024 317.4 million 237.4 million

ADAPY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -34.9 million 1.3 million
March 31, 2025 -66.6 million 669000
Dec. 31, 2024 -35.4 million 4.9 million
Sept. 30, 2024 -54.9 million 3.1 million

ADAPY Net Income

No data available :(

ADAPY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 26.1 million 25.7 million 23.0 million
March 31, 2025 59.6 million 25.4 million 23.3 million
Dec. 31, 2024 151.6 million 50.2 million 24.0 million
Sept. 30, 2024 186.1 million 49.9 million 24.6 million

ADAPY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 264.1 million
March 31, 2025 257.0 million
Dec. 31, 2024 255.9 million
Sept. 30, 2024 255.8 million

ADAPY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 75000 23.0 million 17.9 million -
March 31, 2025 1.2 million 28.9 million 23.3 million 360000
Dec. 31, 2024 1.2 million 39.1 million 21.2 million 506000
Sept. 30, 2024 435000 34.3 million 21.3 million -

ADAPY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 13.7 million 2.5 million
March 31, 2025 7.3 million 879000
Dec. 31, 2024 3.2 million 2.9 million
Sept. 30, 2024 40.9 million 2.8 million

ADAPY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ADAPY

Price: $0.03

52 week price:
0.00
0.28

Earnings Per Share: -0.66 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 7.2 million

Links: